Tenofovir Disoproxil Fumarate
Product Images NDC 69025-101

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 69025-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aizant Drug Research Solutions Pvt Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tenofovir Disoproxil Fumarate Tablets 150 mg Container Label (Tenofovir 150mg 30tablets Label)

Tenofovir Disoproxil Fumarate Tablets contain 150mg of tenofovir disoproxil fumarate, which is equivalent to 123mg of enefovir cisopronl. The tablets should be stored at 25°C (77°F) and the container must be kept tightly closed. The medication should be dispensed only in its original container. The prescribing information should be consulted for the usual dosage. The tablets were manufactured by Azant Drug Research Solutions in India and contain 30 tablets. No barcode information is available.*

FDA Label Image

Tenofovir Disoproxil Fumarate Tablets, 200 mg Container Label (Tenofovir 200mg 30tablets Label)

Tenofovir Disoproxil Fumarate Tablets are a medication used to treat HIV and Hepatitis B infections. Each tablet contains 200 mg of Tenofovir Disoproxil Fumarate, which is equivalent to 163 mg of Tenofovir. The tablets should be stored at a temperature of 25°C (77°F), and kept in the tightly closed original container until dispensed. The dosage should be determined by a medical professional based on the patient's specific condition. These tablets are manufactured by Azant Drug Research Solutions in Hyderabad, Andhra Pradesh, India, and are available in packs of 30 tablets. The product is authorized under Mig. Lic. No. NDC 69025-101-01. The barcode will be provided separately.*

FDA Label Image

Tenofovir Disoproxil Fumarate Tablets, 250 mg Container Label (Tenofovir 250mg 30tablets Label)

This text is a description of Tenofovir Disoproxil Fumarate Tablets, containing 250mg of tenofovir. The tablets need to be stored at 25°C and dispensing should be done in the original container only. The dosage information is available in the Prescribing Information. The tablets are manufactured by Azant Drug Research Solutions Pvt Ltd in Hyderabad, India. The text includes the license number and NDC code, but the barcode isn't provided.*

FDA Label Image

Tenofovir Disoproxil Fumarate Tablets, 300 mg Container Label (Tenofovir 300mg 30tablets Label)

This is a description of Tenofovir Disoproxil Fumarate Tablets. Each tablet contains 300mg of Tenofovir Disoproxil Fumarate which is equivalent to 245mg. The tablets should be stored at 25°C (77°F) and the container should be tightly closed. The dosage and administration instructions can be found in the package insert. The tablets are manufactured by Azant Drug Research Solutions in Hyderabad, India, and the product is available in a container of 30 tablets. The provided NDC code is 69025-103-01. No barcode information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.